Introduction

For those battling advanced prostate cancer, Xtandi (enzalutamide) 40 mg can be a beacon of hope. This medication is specifically designed to combat metastatic castration-resistant prostate cancer (mCRPC), providing a viable option for those who have not responded to other treatments. This article delves into the specifics of Xtandi 40 mg, including its mechanism of action, usage, costs, and financial assistance options.

Understanding Xtandi 40 mg

What is Xtandi 40 mg?

Xtandi 40 mg is an oral medication used to treat mCRPC. Each capsule contains 40 mg of enzalutamide, which works by inhibiting the action of androgens, the male hormones that can promote the growth of prostate cancer cells.

How Xtandi 40 mg Works

Xtandi functions by blocking androgen receptors on cancer cells, preventing these hormones from binding and activating the cancer cells. This inhibition helps to slow down or stop the progression of prostate cancer.

Medical Uses of Xtandi 40 mg

Treatment of Metastatic Castration-Resistant Prostate Cancer

Xtandi 40 mg is prescribed for men with mCRPC. This condition refers to prostate cancer that has spread to other parts of the body and continues to grow even when testosterone levels are reduced to very low levels.

Combination with Other Treatments

Xtandi is often used in combination with other therapies, such as androgen deprivation therapy (ADT), to maximize its effectiveness in controlling cancer progression.

Dosage and Administration

Recommended Dosage

The standard dose of Xtandi is 160 mg per day, which means taking four 40 mg capsules at the same time. It is crucial to follow your doctor’s instructions precisely to ensure the best possible outcome.

How to Take Xtandi 40 mg

Xtandi should be taken at the same time each day, with or without food. Swallow the capsules whole with water, and avoid crushing, chewing, or opening them.

Xtandi Functions by Blocking Androgen